se ha leído el artículo
array:24 [ "pii" => "S1578219017302081" "issn" => "15782190" "doi" => "10.1016/j.adengl.2016.11.021" "estado" => "S300" "fechaPublicacion" => "2017-07-01" "aid" => "1604" "copyright" => "Elsevier España, S.L.U. and AEDV" "copyrightAnyo" => "2017" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2017;108:599-601" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 360 "formatos" => array:3 [ "EPUB" => 31 "HTML" => 258 "PDF" => 71 ] ] "Traduccion" => array:1 [ "en" => array:19 [ "pii" => "S0001731017300601" "issn" => "00017310" "doi" => "10.1016/j.ad.2016.11.018" "estado" => "S300" "fechaPublicacion" => "2017-07-01" "aid" => "1604" "copyright" => "AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2017;108:599-601" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 537 "formatos" => array:3 [ "EPUB" => 63 "HTML" => 159 "PDF" => 315 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letter</span>" "titulo" => "Sorafenib-induced Acute Generalized Exanthematous Pustulosis: An Increasing Association?" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "599" "paginaFinal" => "601" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Pustulosis exantemática generalizada aguda por sorafenib: ¿una relación en aumento?" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 975 "Ancho" => 1301 "Tamanyo" => 434969 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Histopathology. HE 10×. Neutrophilic spongiotic subcorneal pustules. Perivascular infiltrate with lymphocytes and eosinophyles.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "A. Alegre-Sánchez, D. de Perosanz-Lobo, I. Pinilla-Pagnon, E. Muñoz-Zato" "autores" => array:4 [ 0 => array:2 [ "nombre" => "A." "apellidos" => "Alegre-Sánchez" ] 1 => array:2 [ "nombre" => "D." "apellidos" => "de Perosanz-Lobo" ] 2 => array:2 [ "nombre" => "I." "apellidos" => "Pinilla-Pagnon" ] 3 => array:2 [ "nombre" => "E." "apellidos" => "Muñoz-Zato" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1578219017302081" "doi" => "10.1016/j.adengl.2016.11.021" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017302081?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017300601?idApp=UINPBA000044" "url" => "/00017310/0000010800000006/v3_201707250313/S0001731017300601/v3_201707250313/en/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S1578219017302093" "issn" => "15782190" "doi" => "10.1016/j.adengl.2016.12.023" "estado" => "S300" "fechaPublicacion" => "2017-07-01" "aid" => "1603" "copyright" => "Elsevier España, S.L.U. and AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2017;108:601-3" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 331 "formatos" => array:3 [ "EPUB" => 27 "HTML" => 223 "PDF" => 81 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letter</span>" "titulo" => "Expanding the Genotype of Sjögren–Larsson Syndrome: A New Case Due to Two Novel Mutations" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "601" "paginaFinal" => "603" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Ampliando el genotipo del síndrome de Sjögren-Larsson: un nuevo caso causado por dos nuevas mutaciones" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1716 "Ancho" => 1980 "Tamanyo" => 1335406 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">A skin biopsy from an armpit revealed hyperkeratosis, psoriasiform epidermal hyperplasia and slightly thickened granular layer in epidermis, and mild perivascular inflammatory infiltrate of mononuclear cells in papillary dermis (H&E 4×).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "E. García-Peris, I. Latour-Álvarez, M. Pestana-Eliche, R. Sánchez" "autores" => array:4 [ 0 => array:2 [ "nombre" => "E." "apellidos" => "García-Peris" ] 1 => array:2 [ "nombre" => "I." "apellidos" => "Latour-Álvarez" ] 2 => array:2 [ "nombre" => "M." "apellidos" => "Pestana-Eliche" ] 3 => array:2 [ "nombre" => "R." "apellidos" => "Sánchez" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S0001731017300595" "doi" => "10.1016/j.ad.2016.12.015" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017300595?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017302093?idApp=UINPBA000044" "url" => "/15782190/0000010800000006/v1_201706300050/S1578219017302093/v1_201706300050/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S1578219017301427" "issn" => "15782190" "doi" => "10.1016/j.adengl.2017.05.001" "estado" => "S300" "fechaPublicacion" => "2017-07-01" "aid" => "1574" "copyright" => "Elsevier España, S.L.U. and AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2017;108:597-9" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 593 "formatos" => array:3 [ "EPUB" => 33 "HTML" => 438 "PDF" => 122 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letter</span>" "titulo" => "Oral Oxybutynin for Local and Multifocal Hyperhidrosis: A Multicenter Study" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "597" "paginaFinal" => "599" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Estudio multicéntrico sobre el uso de oxibutinina oral en hiperhidrosis local y multifocal" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2031 "Ancho" => 2663 "Tamanyo" => 124725 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Numbers of patients with given Hyperhidrosis Disease Severity Scale (HDSS) scores before (left) and after (right) treatment.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "T. Toledo-Pastrana, J. Márquez-Enríquez, J.F. Millán-Cayetano" "autores" => array:3 [ 0 => array:2 [ "nombre" => "T." "apellidos" => "Toledo-Pastrana" ] 1 => array:2 [ "nombre" => "J." "apellidos" => "Márquez-Enríquez" ] 2 => array:2 [ "nombre" => "J.F." "apellidos" => "Millán-Cayetano" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731016304434" "doi" => "10.1016/j.ad.2016.11.013" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731016304434?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017301427?idApp=UINPBA000044" "url" => "/15782190/0000010800000006/v1_201706300050/S1578219017301427/v1_201706300050/en/main.assets" ] "en" => array:15 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letter</span>" "titulo" => "Sorafenib-induced Acute Generalized Exanthematous Pustulosis: An Increasing Association?" "tieneTextoCompleto" => true "saludo" => "Dear Editor," "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "599" "paginaFinal" => "601" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "A. Alegre-Sánchez, D. de Perosanz-Lobo, I. Pinilla-Pagnon, E. Muñoz-Zato" "autores" => array:4 [ 0 => array:4 [ "nombre" => "A." "apellidos" => "Alegre-Sánchez" "email" => array:1 [ 0 => "adrian.alegresanchez@gmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "D." "apellidos" => "de Perosanz-Lobo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 2 => array:3 [ "nombre" => "I." "apellidos" => "Pinilla-Pagnon" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 3 => array:3 [ "nombre" => "E." "apellidos" => "Muñoz-Zato" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Dermatology Service, Ramon y Cajal Hospital, Madrid, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Pathology Sevice, Ramon y Cajal Hospital, Madrid, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Pustulosis exantemática generalizada aguda por sorafenib: ¿una relación en aumento?" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 773 "Ancho" => 3167 "Tamanyo" => 259430 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Clinical evolution. (a) Exanthema affecting mainly face, upper trunk, superior limbs with isolated patches on abdomen and lower extremities. (b) Closer image showing isolated pustules surrounded by erythema. (c) Evolution of the exanthema 5 days after Sorafenib discontinuation. Mild erythema and desquamation on upper trunk with pustules resolution.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Acute Generalized Exanthematous Pustulosis (AGEP) is an acute eruption considered as a severe cutaneous adverse reaction (SCAR) related to drugs. Although antibiotics are the most common triggers, many other drugs have been associated with AGEP. More rarely, cases of nun-drug-related AGEP have been reported, due to viral or bacterial infections, spider bites or mercury hypersensitivity.<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">1</span></a> Here, we present the case of an AGEP triggered by the kinase-inhibitor Sorafenib and we expose a brief review of similar cases reported.</p><p id="par0010" class="elsevierStylePara elsevierViewall">A 78-year-old woman presented to the Emergency Department with a 6-week history of an extensive, pruriginous exanthema consisting of erythematous and edematous plaques in the face, chest and upper extremities, with small isolated pustules (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>). Mucous membrane involvement was confined to the lips. Neither fever nor other systemic symptoms were evident. Two months before, she had initiated treatment with sorafenib due to an unresectable hepatocarcinoma. Skin reaction developed gradually two days after initiating the treatment.</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0015" class="elsevierStylePara elsevierViewall">Laboratory examination revealed a hypereosinophilia of 1.4<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>10<span class="elsevierStyleSup">9</span>/L. A skin biopsy was performed, rendering typical histological features of AGEP (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>). Attending to the validated EuroSCAR scoring system,<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">2</span></a> our case was then classified as a <span class="elsevierStyleItalic">Probable</span> AGEP. Sorafenib was discontinued immediately, and treatment with intravenous methylprednisolone 1<span class="elsevierStyleHsp" style=""></span>mg/kg was initiated. Cutaneous lesions improved rapidly and were almost totally resolved after a week. This clinical evolution strongly supports the diagnosis of sorafenib-induced AGEP.</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0020" class="elsevierStylePara elsevierViewall">AGEP is characterized by numerous, small, non-follicular and sterile pustules arising within extensive areas of edematous erythema. Fever and leukocytosis are common findings and severe cases of AGEP can associate visceral involvement. Mucous membrane might also be affected. Time interval between drug administration and the skin eruption onset is typically 48<span class="elsevierStyleHsp" style=""></span>h, although it varies from 1 day to 4 weeks. It typically resolves in two weeks after drug discontinuation.<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1,2</span></a> Main differential diagnoses of AGEP are other pustular diseases, such as pustular psoriasis, and other severe cutaneous adverse reactions, such as Stevens Johnson syndrome (SJS) or Toxic Epidermal Necrolysis. Compared to AGEP, in SJS/NET, mucosal involvement and skin detachment (Nikolsky sign) are a constant. However, the possibility of overlap of different severe cutaneous reactions have been recently discussed in the literature.<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">3</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">Sorafenib is a multikinase inhibitor that mainly target tumor cell angiogenesis, first used in advanced renal cell cancer and unresectable hepatocellular carcinoma with recent indications in other cancers.<a class="elsevierStyleCrossRef" href="#bib0105"><span class="elsevierStyleSup">4</span></a> It inhibits multiple tyrosine-kinases, such as RAF-1 and B-RAF, and it blocks tyrosine-kinases receptors, such as platelet-derived growth factor receptor (PDGFR), related with carcinogenesis.<a class="elsevierStyleCrossRef" href="#bib0120"><span class="elsevierStyleSup">7</span></a></p><p id="par0030" class="elsevierStylePara elsevierViewall">Patients under treatment with multikinase inhibitors usually develop cutaneous reactions. In a prospective study, up to 72% of the patients taking sorafenib presented dermatological symptoms.<a class="elsevierStyleCrossRefs" href="#bib0105"><span class="elsevierStyleSup">4,7</span></a> Most of these reactions are maculopapular rashes and other grade 1–2 severity adverse reactions that can be easily managed. Other non-severe skin reactions that can be found are hand–foot skin reaction, stomatitis, subungual splinter hemorrhages, facial erythema or alopecia.<a class="elsevierStyleCrossRefs" href="#bib0105"><span class="elsevierStyleSup">4,7</span></a></p><p id="par0035" class="elsevierStylePara elsevierViewall">However, some of these patients develop SCARs related to sorafenib, such as Drug Reaction with Eosynophilia and Systemic Symptoms (DRESS), SJS or AGEP.<a class="elsevierStyleCrossRefs" href="#bib0110"><span class="elsevierStyleSup">5,6,8,9</span></a></p><p id="par0040" class="elsevierStylePara elsevierViewall">To our knowledge, only 2 more cases of sorafenib-induced acute exanthematous pustulosis have been published, being one of them an acute localized exanthematous pustulosis (ALEP) and the other one a complete AGEP.<a class="elsevierStyleCrossRefs" href="#bib0110"><span class="elsevierStyleSup">5,6</span></a> The main features of these cases are presented in <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>. Interestingly, all the three cases occurred in women who were under treatment with sorafenib due to unresectable hepatocarcinoma. Cases of AGEP have also been reported associated with other multikinase inhibitors such as imatinib.<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">10</span></a> Therefore; we believe that the association between kinase-inhibitors and AGEP might be an under-reported entity with an increasing incidence due to the appearance of new drugs of this nature.</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0045" class="elsevierStylePara elsevierViewall">In conclusion, we report a new case of sorafenib-induced AGEP. We should be aware of this cutaneous side effect of sorafenib and other multikinase inhibitors, given that drug discontinuation is the key point on AGEP treatment.</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Conflict of interests</span><p id="par0050" class="elsevierStylePara elsevierViewall">The authors declare no conflict of interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Conflict of interests" ] 1 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "multimedia" => array:3 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 773 "Ancho" => 3167 "Tamanyo" => 259430 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Clinical evolution. (a) Exanthema affecting mainly face, upper trunk, superior limbs with isolated patches on abdomen and lower extremities. (b) Closer image showing isolated pustules surrounded by erythema. (c) Evolution of the exanthema 5 days after Sorafenib discontinuation. Mild erythema and desquamation on upper trunk with pustules resolution.</p>" ] ] 1 => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 975 "Ancho" => 1301 "Tamanyo" => 437187 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Histopathology. HE 10×. Neutrophilic spongiotic subcorneal pustules. Perivascular infiltrate with lymphocytes and eosinophyles.</p>" ] ] 2 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Case \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Sex, age (years old) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Sorafenib indication \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Latency \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Distribution \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Fever \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Laboratory abnormalities \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Mucosal involvement \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Skin biopsy \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Resolution \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Liang, CP et al. (2011)<a class="elsevierStyleCrossRef" href="#bib0110"><span class="elsevierStyleSup">5</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Woman, 59 yo \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Hepatocarcinoma \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2 weeks \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Localized: lower limbs \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">No \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">No \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">No \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Subcorneal pustules with intraepidermal spongiform \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Spontaneous improvement after sorafenib discontinuation \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Pretel, M et al. (2014)<a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">6</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Woman, 50 yo \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Hepatocarcinoma \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">4 weeks \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Generalized: neck, abdomen, buttocks and lower limbs \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">No \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Neutrophilia 7.1<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>10<span class="elsevierStyleSup">9</span>/L \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">No \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Subcorneal pustules with papillary edema \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Spontaneous improvement after sorafenib discontinuation \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Our case (2016) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Woman, 78 yo \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Hepatocarcinoma \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2 days \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Generalized: chest, neck, facial area and upper limbs \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">No \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Eosinophilia 1.4<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>10<span class="elsevierStyleSup">9</span>/L \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Labial mucosa desquamation \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Subcorneal pustules with papillary edema. Low necrosis keratinocyte and isolated eosinophils \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Improvement after sorafenib discontinuation and corticosteroids treatment \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1450912.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Demographical and clinical features of sorafenib-induced AGEP/ALEP cases.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:10 [ 0 => array:3 [ "identificador" => "bib0055" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Acute generalized exanthematous pustulosis (AGEP): a review and update" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J. Szatkowski" 1 => "R.A. Schwartz" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Am Dermatol" "fecha" => "2015" "volumen" => "73" "paginaInicial" => "843" "paginaFinal" => "848" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0060" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Acute generalized exanthematous pustulosis (AGEP): a clinical reaction pattern?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "A. Sidoroff" 1 => "S. Halevy" 2 => "J.N. Bavinck" 3 => "L. Vaillant" 4 => "J.C. Roujeau" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Cutan Pathol" "fecha" => "2001" "volumen" => "28" "paginaInicial" => "113" "paginaFinal" => "119" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11168761" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0065" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Toxicodermias graves: ¿existen las formas combinadas?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "C. Horcajada-Reales" 1 => "A. Pulido-Pérez" 2 => "R. Suárez-Fernández" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ad.2015.08.006" "Revista" => array:6 [ "tituloSerie" => "Actas Dermo-sifiliográficas" "fecha" => "2016" "volumen" => "107" "paginaInicial" => "23" "paginaFinal" => "33" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26520037" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0105" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Dermatologic symptoms associated with the multikinase inhibitor sorafenib" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "C. Robert" 1 => "C. Mateus" 2 => "A. Spatz" 3 => "J. Wechsler" 4 => "B. Escudier" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Am Dermatol" "fecha" => "2009" "volumen" => "60" "paginaInicial" => "299" "paginaFinal" => "305" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0110" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Sorafenib-induced acute localized exanthematous pustulosis in a patient with hepatocellular carcinoma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "C.P. Liang" 1 => "C.S. Yang" 2 => "J.L. Shen" 3 => "Y.J. Chen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-2133.2011.10377.x" "Revista" => array:6 [ "tituloSerie" => "Br J Dermatol" "fecha" => "2011" "volumen" => "165" "paginaInicial" => "443" "paginaFinal" => "445" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21495998" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0115" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Acute generalized exanthematous pustulosis induced by sorafenib" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "M. Pretel" 1 => "M. Iñarrairaegui" 2 => "J.M. Lera" 3 => "L. Aguado" 4 => "M.A. Idoate" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jamadermatol.2013.6924" "Revista" => array:6 [ "tituloSerie" => "JAMA Dermatol" "fecha" => "2014" "volumen" => "150" "paginaInicial" => "664" "paginaFinal" => "666" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24671701" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0120" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cutaneous reactions to chemotherapeutic drugs and targeted therapies for cancer. Part II. Targeted therapies" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "C.M. Reyes-Habito" 1 => "E.K. Roh" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Am Dermatol" "fecha" => "2014" "volumen" => "71" "paginaInicial" => "217.e1" "paginaFinal" => "217.e11" ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0125" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A case of Sorafenib-induced DRESS syndrome in hepatocelluar carcinoma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D.K. Kim" 1 => "S.W. Lee" 2 => "H.S. Nam" 3 => "D.S. Jeon" 4 => "N.R. Park" 5 => "Y.H. Nam" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.4166/kjg.2016.67.6.337" "Revista" => array:6 [ "tituloSerie" => "Korean J Gastroenterol" "fecha" => "2016" "volumen" => "67" "paginaInicial" => "337" "paginaFinal" => "340" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27312836" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0130" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Sorafenib induces delayed-onset cutaneous hypersensitivity: a case series" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "K.H. Sohn" 1 => "S.Y. Oh" 2 => "K.W. Lim" 3 => "M.Y. Kim" 4 => "S.Y. Lee" 5 => "H.R. Kang" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.4168/aair.2015.7.3.304" "Revista" => array:6 [ "tituloSerie" => "Allergy Asthma Immunol Res" "fecha" => "2015" "volumen" => "7" "paginaInicial" => "304" "paginaFinal" => "307" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25749785" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0100" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Acute generalized exanthematous pustulosis (AGEP) secondary to imatinib in a patient with chronic myeloid leukaemia" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "A.D. Scott" 1 => "M. Lee" 2 => "F. Kubba" 3 => "A. Chu" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/ced.12479" "Revista" => array:6 [ "tituloSerie" => "Clin Exp Dermatol" "fecha" => "2015" "volumen" => "40" "paginaInicial" => "926" "paginaFinal" => "927" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25266712" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15782190/0000010800000006/v1_201706300050/S1578219017302081/v1_201706300050/en/main.assets" "Apartado" => array:4 [ "identificador" => "6157" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Case and Research Letters" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15782190/0000010800000006/v1_201706300050/S1578219017302081/v1_201706300050/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017302081?idApp=UINPBA000044" ]
año/Mes | Html | Total | |
---|---|---|---|
2024 Noviembre | 9 | 13 | 22 |
2024 Octubre | 64 | 31 | 95 |
2024 Septiembre | 75 | 27 | 102 |
2024 Agosto | 114 | 42 | 156 |
2024 Julio | 66 | 43 | 109 |
2024 Junio | 72 | 49 | 121 |
2024 Mayo | 45 | 41 | 86 |
2024 Abril | 79 | 45 | 124 |
2024 Marzo | 100 | 30 | 130 |
2024 Febrero | 88 | 28 | 116 |
2024 Enero | 53 | 27 | 80 |
2023 Diciembre | 63 | 15 | 78 |
2023 Noviembre | 71 | 32 | 103 |
2023 Octubre | 72 | 23 | 95 |
2023 Septiembre | 68 | 36 | 104 |
2023 Agosto | 44 | 16 | 60 |
2023 Julio | 61 | 29 | 90 |
2023 Junio | 45 | 21 | 66 |
2023 Mayo | 64 | 23 | 87 |
2023 Abril | 50 | 23 | 73 |
2023 Marzo | 65 | 27 | 92 |
2023 Febrero | 54 | 34 | 88 |
2023 Enero | 29 | 33 | 62 |
2022 Diciembre | 59 | 38 | 97 |
2022 Noviembre | 21 | 28 | 49 |
2022 Octubre | 46 | 22 | 68 |
2022 Septiembre | 17 | 25 | 42 |
2022 Agosto | 27 | 41 | 68 |
2022 Julio | 21 | 35 | 56 |
2022 Junio | 19 | 31 | 50 |
2022 Mayo | 39 | 35 | 74 |
2022 Abril | 41 | 27 | 68 |
2022 Marzo | 44 | 39 | 83 |
2022 Febrero | 24 | 28 | 52 |
2022 Enero | 33 | 35 | 68 |
2021 Diciembre | 33 | 49 | 82 |
2021 Noviembre | 46 | 49 | 95 |
2021 Octubre | 48 | 50 | 98 |
2021 Septiembre | 31 | 33 | 64 |
2021 Agosto | 37 | 29 | 66 |
2021 Julio | 20 | 26 | 46 |
2021 Junio | 23 | 14 | 37 |
2021 Mayo | 34 | 40 | 74 |
2021 Abril | 50 | 35 | 85 |
2021 Marzo | 50 | 27 | 77 |
2021 Febrero | 43 | 30 | 73 |
2021 Enero | 21 | 19 | 40 |
2020 Diciembre | 32 | 24 | 56 |
2020 Noviembre | 17 | 21 | 38 |
2020 Octubre | 26 | 10 | 36 |
2020 Septiembre | 20 | 18 | 38 |
2020 Agosto | 26 | 14 | 40 |
2020 Julio | 22 | 17 | 39 |
2020 Junio | 25 | 29 | 54 |
2020 Mayo | 13 | 13 | 26 |
2020 Abril | 25 | 14 | 39 |
2020 Marzo | 15 | 10 | 25 |
2020 Febrero | 4 | 0 | 4 |
2020 Enero | 4 | 0 | 4 |
2019 Diciembre | 4 | 0 | 4 |
2019 Noviembre | 4 | 0 | 4 |
2019 Septiembre | 4 | 0 | 4 |
2019 Agosto | 4 | 0 | 4 |
2019 Julio | 4 | 0 | 4 |
2019 Junio | 4 | 0 | 4 |
2019 Mayo | 5 | 0 | 5 |
2019 Abril | 4 | 0 | 4 |
2019 Febrero | 4 | 0 | 4 |
2018 Diciembre | 2 | 0 | 2 |
2018 Octubre | 2 | 0 | 2 |
2018 Septiembre | 4 | 0 | 4 |
2018 Febrero | 9 | 1 | 10 |
2018 Enero | 19 | 3 | 22 |
2017 Diciembre | 32 | 5 | 37 |
2017 Noviembre | 18 | 5 | 23 |
2017 Octubre | 22 | 8 | 30 |
2017 Septiembre | 24 | 11 | 35 |
2017 Agosto | 34 | 14 | 48 |
2017 Julio | 45 | 23 | 68 |
2017 Junio | 5 | 1 | 6 |